Pharmaceutical
| Sat 20 Jun 2026
Geneva, June 20 -- Metagenomi Therapeutics Inc has applied WIPO patent for Class 2, Type V Crispr Systems. Brown Christopher, Goltsman Daniela S A, Matheus Carnevali Paula B, Hackney Margaret, Temoche-diaz Morayma, Thomas Brian C, Luong Thao, Butterfield Cristina Noel, Senger Kate, Devoto Audra, Alexander Lisa, Nocedal Isabel, B..